ASMB — ASSEMBLY BIOSCIENCES INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ASSEMBLY BIOSCIENCES INC (ASMB)
ASSEMBLY BIOSCIENCES INC (ASMB) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Steve Cohen (Point72 Asset Management), valued at $20M. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ASMB
How many top investors track ASMB
A small number of top investors own this.
ASMB Ownership Composition
How ASSEMBLY BIOSCIENCES INC is held across tracked investor types, based on reported 13F positions.
- Hedge Funds57.0%
- Other43.0%
Tracked investors reporting ASMB
- Steve CohenMar 31, 2026Point72 Asset ManagementShares344.1KValue$9.5M% Portfolio0.01%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares233.7KValue$6.5M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares25.4KValue$705.9K% Portfolio0.00%
Recent activity
- $3.3MFeb 17, 2026
- $6.5MMay 15, 2026
- New$20.4MFeb 17, 2026
- New$705.9KMay 15, 2026
- New$9.5MMay 15, 2026
- New$1.4MNov 14, 2025
Frequently asked questions
- How many institutional investors hold ASMB?
- 3 tracked institutional investors disclosed a position in ASMB (ASSEMBLY BIOSCIENCES INC) in their most recent 13F filing.
- Who is the largest institutional holder of ASMB?
- Steve Cohen, Point72 Asset Management, holds the largest disclosed position in ASMB, valued at $20M.
- Did institutional ownership of ASMB increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 0 fully exited ASMB.
- Where does this ASMB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.